Companies

Case Study:

AmeriPath

“Summit helped us successfully execute our acquisition strategy, providing invaluable expertise along with capital.”

Jim New, Former CEO

Location:
Riviera Beach, FL
Leadership:

James New

Founded in:
1982
invested in:
1994
Status:

IPO 1997

Acquired by Quest Diagnostics 2007

Summit Team:
Thomas S. Roberts
Case Study:

AmeriPath

22x revenue growth over 6-year investment

Acquired more than 35 pathology practices

IPO in 1997

Later acquired by Quest Diagnostics in 2007

Founded by physicians, AmeriPath specialized in dermatopathalogy, the review and interpretation of human tissue biopsies. While the company had developed a strong and loyal referring physician customer base in the southeastern United States, the founders aspired to expand the business to a national scale through the consolidation of the fragmented industry. The company turned to Summit for financing and strategic guidance.

How Summit helped:

  • Provided growth equity capital, subordinated debt and arranged for a bank line of credit
  • At the founders’ request, recruited a seasoned healthcare executive as CEO
  • Built an independent board of directors
  • Led several bank financings to facilitate a successful acquisition strategy

AmeriPath completed its IPO in 1997, and Summit exited the investment in 2000. The company continued to grow rapidly, expanding across the United States and broadening its services to offer a range of anatomic pathology laboratory testing and information services. In 2007, AmeriPath was acquired by Quest Diagnostics for $2 billion.

  • Boston

    Summit Partners

    222 Berkeley Street, 18th floor

    Boston, MA 02116

    United States

    T: +1 617.824.1000

    F: +1 617.824.1100

    London

    Summit Partners LLP

    Queensberry House, 3rd Floor
    3 Old Burlington Street

    London W1S 3AE

    United Kingdom

    T: +44 (0)20 7659 7500

    F: +44 (0)20 7659 7550

  • Menlo Park

    Summit Partners

    200 Middlefield Road, Suite 200

    Menlo Park, CA 94025

    United States

    T: +1 650.321.1166

    F: +1 650.321.1188